Daniel Gusenleitner

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Bjoern Chapuy, Margaretha G.M. Roemer, Chip Stewart et al. · Blood · 2015 · 590 citations · Full text

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

Scott J. Rodig, Daniel Gusenleitner, Donald Jackson et al. · Science Translational Medicine · 2018 · 567 citations

Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma

Christopher D. Carey, Daniel Gusenleitner, Mikel Lipschitz et al. · Blood · 2017 · 325 citations · Full text

Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients

Priyanka B. Subrahmanyam, Zhiwan Dong, Daniel Gusenleitner et al. · Journal for ImmunoTherapy of Cancer · 2018 · 188 citations · Full text

Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade

Sachet A. Shukla, Pavan Bachireddy, Bastian Schilling et al. · Cell · 2018 · 167 citations · Full text

Cancer Immunosurveillance, Medicine, Immunology +5